Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloidosis in Transthyretin (TTR)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07170306
What this trial is testing

Cardiac Amyloidosis in Patients With Aortic Stenosis

Who this might be right for
Aortic StenosisTransthyretin Amyloid Cardiomyopathy
Shanghai Zhongshan Hospital 143
Not applicableUnknownNCT03098901
What this trial is testing

Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease

Who this might be right for
Cardiac TTR Amyloidosis
Kaplan Medical Center 100
Early research (Phase 1)Study completedNCT05201911
What this trial is testing

Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis

Who this might be right for
Amyloidosis; Systemic
Attralus, Inc. 13
Large-scale testing (Phase 3)Study completedNCT00925002
What this trial is testing

Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis

Who this might be right for
ATTR-PN
Pfizer 93
Not applicableLooking for participantsNCT07112066
What this trial is testing

Multimodality Cardiac Imaging for Disease Progression in ATTR-CM

Who this might be right for
Amyloidosis Cardiac
Dominik Benz 50
Very early researchStudy completedNCT04899180
What this trial is testing

Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

Who this might be right for
Aortic StenosisTransthyretin AmyloidosisTransthyretin Amyloid Cardiomyopathy+1 more
Mayo Clinic 4
Not applicableStudy completedNCT06365593
What this trial is testing

HATTR Polyneuropathy in Russia

Who this might be right for
Hereditary Transthyretin Amyloidosis
AstraZeneca 100
Not applicableStudy completedNCT03720275
What this trial is testing

Early and Systematic Screening in Chronic Neuropathy

Who this might be right for
Amyloid Neuropathies, Familial
University Hospital, Bordeaux 130
Early research (Phase 1)Study completedNCT06527755
What this trial is testing

Assess the PK, PD, Safety and Tolerability of Eplontersen in Healthy Chinese Volunteers

Who this might be right for
Transthyretin-mediated Amyloidosis
AstraZeneca 12
Not applicableLooking for participantsNCT07196839
What this trial is testing

Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study

Who this might be right for
Transthyretin (TTR) Amyloid Cardiomyopathy
University of Texas Southwestern Medical Center 50
Large-scale testing (Phase 3)WithdrawnNCT04418024
What this trial is testing

Efficacy and Safety of AG10 in Subjects with Transthyretin Amyloid Polyneurophathy

Who this might be right for
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
Eidos Therapeutics, a BridgeBio company
Testing effectiveness (Phase 2)Study completedNCT00630864
What this trial is testing

The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis

Who this might be right for
Transthyretin-associated Amyloidosis With Polyneuropathy
Pfizer 21
Not applicableStudy completedNCT03431896
What this trial is testing

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

Who this might be right for
AmyloidosisAmyloidAmyloid Neuropathies, Familial+4 more
The Cleveland Clinic 37
Testing effectiveness (Phase 2)Study completedNCT03458130
What this trial is testing

Study of AG10 in Amyloid Cardiomyopathy

Who this might be right for
Familial ATTR-CM (ATTRm-CM, or FAC)Wild-type ATTR-CM (ATTRwt-CM)
Eidos Therapeutics, a BridgeBio company 49
Early research (Phase 1)Study completedNCT03294707
What this trial is testing

Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10

Who this might be right for
Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company 56
Large-scale testing (Phase 3)Study completedNCT03860935
What this trial is testing

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Who this might be right for
AmyloidosisAmyloid CardiomyopathyTransthyretin Amyloidosis+2 more
Eidos Therapeutics, a BridgeBio company 632
Early research (Phase 1)Study completedNCT04360434
What this trial is testing

First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy

Who this might be right for
Amyloid Transthyretin Cardiomyopathy
Neurimmune AG 46
Testing effectiveness (Phase 2)UnknownNCT06539208
What this trial is testing

A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

Who this might be right for
Transthyretin Amyloidosis PolyneuropathyTransthyrexin Amyloidosis Cardiomyopathy
YolTech Therapeutics Co., Ltd 31
Post-approval studies (Phase 4)Active Not RecruitingNCT05489523
What this trial is testing

Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation

Who this might be right for
Transthyretin Cardiac Amyloidosis
University of Texas Southwestern Medical Center 25
Post-approval studies (Phase 4)Looking for participantsNCT07695701
What this trial is testing

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

Who this might be right for
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)AmyloidosisAmyloid Cardiomyopathy+1 more
Eidos Therapeutics, a BridgeBio company 150
Next Page